Corbus Wins With FDA Fast Track Designation
Corbus Pharmaceuticals announced that the FDA has designated as a Fast Track development program and granted Orphan Drug Designation to the its investigational new drug Resunab.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 241Merus Files for IPO
Merus has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now
Cowen says the way to play biotech is with large cap sector leaders that can beat earnings estimates. It also thinks third-quarter earnings beats could highlight the risk of not owning biotech now.
Myokardia Sets Terms for IPO
MyoKardia expects to price more than 4 million shares in the range of $15 to $17 in an IPO valued up to more than $91 million.
Ellipse Technologies Gears Up for IPO
Ellipse Technologies has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Beigene Readies Itself for IPO
Beigene has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Are Valeant Earnings Enough?
Valeant Pharmaceuticals reported its third-quarter financial results before the markets opened on Monday.
5 Top Biotech Movers of the Past Week
Over the past week, a few biotech companies, such as Cepheid and Valeant Pharmaceuticals, made absolutely massive runs.
PCT Therapeutics Rises on Analyst Upgrade
PTC Therapeutics traded higher Friday morning following the release of an incredibly positive analyst report.
Cempra Slips on Phase 3 Results
Cempra made waves in the market on Friday morning on Phase 3 trial news. Despite announcing positive top-line results, shares plunged by a third.
Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings
These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
Why Analysts Will Have to Slash Their Hospital Price Targets
ThinkstockIn the world investing, a fire or problem at one company often means that its peers and rivals are likely to have many of the same risks. In the case of HCA Holdings, Inc.…
Appellis Pharma Files for IPO
Appellis Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.
Are UnitedHealth Earnings Enough for Investors?
ThinkstockUnitedHealth Group Inc. (NYSE: UNH) released its third-quarter financial results before the markets opened on Thursday. The health insurance giant reported $1.65 in earnings per share (EPS) on $41.49 in revenue. That compared to…
How the Technology of One Small Biotech Can Save Tetraphase
Tetraphase Pharmaceuticals continues to reel from the spectacular and unexpected failure of its flagship candidate, eravacycline.